In The News – May 16, 2018
In A First, FDA Approves Drug Meant to Mitigate Symptoms of Opioid Withdrawal
“The Food and Drug Administration on Wednesday approved for the first time a drug meant to mitigate the symptoms of opioid withdrawal — rather than an underlying dependency — giving American physicians a new tool to help patients begin treatment.
The drug, lofexidine, will be manufactured by Kentucky-based US WorldMeds and marketed as Lucemyra.
The new drug is viewed as an important bridge to some forms of medication-assisted treatment, which have been the focus of many state and federal efforts to improve addiction treatment and have been seen as an effective way to help many patients.”